Among the 25 consecutive treatment-naive BRAF-V600/NRAS mutant patients with locally advanced or metastatic melanoma who were tested at baseline, the same mutation of the tissues was found in the plasma in 15 patients, with a global concordance of 60%. Here, BRAF is linked to metastatic melanoma.